Empagliflozin combined with short-term intensive insulin therapy improves glycemic variability and 1,5-anhydroglucitol in patients with type 2 diabetes: a randomized clinical trial-Reference-Cited by-同舟云学术

Empagliflozin combined with short-term intensive insulin therapy improves glycemic variability and 1,5-anhydroglucitol in patients with type 2 diabetes: a randomized clinical trial

Published:2023-10-31 Issue: Volume: Page:
ISSN:0973-3930
Container-title:International Journal of Diabetes in Developing Countries
language:en
Short-container-title:Int J Diabetes Dev Ctries

Author:

Hao Zhihua^ORCID,Zhao Yuliang,Zhu Qiuxiao,Ge Yanhong,Liu Zibo,Chen Yanxia,Jiao Lijing,Zhao Xin,Wang Xing,Wang Jing,Zhou Jing,Hao Huiyao,Hao Yongmei,Zhou Hong,Wang Mian,Zhang Lihui^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13410-023-01271-8.pdf

Reference29 articles.

1. Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997Published 2020 Apr 28. https://doi.org/10.1136/bmj.m997.

2. Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol. 2021;20(1):9Published 2021 Jan 7 https://doi.org/10.1186/s12933-020-01200-7.

3. Handsaker JC, Brown SJ, Bowling FL, et al. Contributory factors to unsteadiness during walking up and down stairs in patients with diabetic peripheral neuropathy. Diabetes Care. 2014;37(11):3047–53. https://doi.org/10.2337/dc14-0955.

4. Gómez-Peralta F, Carramiñana-Barrera F, Félix-Redondo FJ, Fraile-Gómez J, Extreme Rescue Study Group. Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study. Int J Clin Pract. 2012;66(10):959–68. https://doi.org/10.1111/j.1742-1241.2012.03000.x.

5. Zhou J, Zheng F, Guo X, et al. Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs. Diabetes Metab Res Rev. 2015;31(7):725–33. https://doi.org/10.1002/dmrr.2661.